Researchers observe how lung cancer patients fare in real life
NCT ID NCT07173946
First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study will follow 96 adults with extensive-stage small cell lung cancer to see how they are treated in everyday hospital settings and how they respond. Doctors will choose treatments as usual, and researchers will collect data from medical records and regular check-ins every 3 months. The goal is to learn what works best in real-world practice to improve future care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could provide valuable insights into how current treatments work in everyday practice, helping doctors refine strategies for ES-SCLC.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly test new therapies. Results may be limited by the small number of participants (96) and real-world variability.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EXTENSIVE-STAGE SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can donor immune cells boost lung cancer remission?
- Could adding chest radiation extend life in advanced lung cancer?
- Can a pill restore the Body's tumor suppressor to fight multiple cancers?
- Can a new drug tame advanced solid tumors?
- Can a remote approach bring clinical trials to lung cancer patients?
- Which palliative care approach boosts quality of life in advanced lung cancer?